KECORT Study: An International E-delphi Study On The Treatment Of Keloids Using Intralesional Corticosteroids In Clinical Practice
Qi Yin (MD), Albert Wolkerstorfer (MD, PhD),
BACKGROUND
Keloid management, specifically intralesional corticosteroid administration (ICA) as a first-line treatment, faces significant variability in global clinical practice. This hinders comparability of treatment results, underscoring the need for universal treatment guidelines to standardize ICA and enhance consistency for clinical practice.
CONCLUSION
This e-Delphi study provides important clinical recommendations on essential aspects of ICA in keloids. By implementing these recommendations, uniformity of ICA in keloid treatment will increase and treatment results will become more comparable. Additionally, better treatment results may be achieved.
The methods, results, figures and the downloadable PDF are available to subscribers.